Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Debt Ratio (2017 - 2025)

United Therapeutics (UTHR) has disclosed Debt Ratio for 14 consecutive years, with 0.03 as the latest value for Q1 2025.

  • Quarterly Debt Ratio fell 72.04% to 0.03 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.03 through Mar 2025, down 72.04% year-over-year, with the annual reading at 0.04 for FY2024, 58.29% down from the prior year.
  • Debt Ratio hit 0.03 in Q1 2025 for United Therapeutics, down from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.17 in Q1 2021 to a low of 0.03 in Q1 2025.
  • Historically, Debt Ratio has averaged 0.12 across 5 years, with a median of 0.13 in 2023.
  • Biggest five-year swings in Debt Ratio: fell 10.72% in 2021 and later crashed 72.04% in 2025.
  • Year by year, Debt Ratio stood at 0.15 in 2021, then decreased by 14.48% to 0.13 in 2022, then decreased by 26.2% to 0.1 in 2023, then crashed by 58.29% to 0.04 in 2024, then crashed by 36.6% to 0.03 in 2025.
  • Business Quant data shows Debt Ratio for UTHR at 0.03 in Q1 2025, 0.04 in Q4 2024, and 0.06 in Q3 2024.